Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

Ligand Pharmaceuticals Incorporated (LGDN.F)

Compare
87.50
-8.00
(-8.38%)
At close: April 4 at 4:18:18 PM GMT+2

Research Analysis

Revenue vs. Earnings

Revenue 42.81M
Earnings -31.09M

Q1'24

Q2'24

Q3'24

Q4'24

-50M
0
50M
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 6676
Avg. Estimate 37.84M44.3M191.3M227.73M
Low Estimate 33.89M41.77M185M208.44M
High Estimate 40.4M48.56M196.6M243.1M
Year Ago Sales 30.98M41.53M167.13M191.3M
Sales Growth (year/est) 22.16%6.68%14.46%19.04%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
LGDN.F --------
S&P 500 6.57%6.54%9.73%14.28%

Upgrades & Downgrades

Reiterates Benchmark: Buy to Buy 12/23/2024
Maintains Barclays: Overweight to Overweight 12/16/2024
Maintains RBC Capital: Outperform to Outperform 12/11/2024
Reiterates HC Wainwright & Co.: Buy to Buy 12/11/2024
Maintains RBC Capital: Outperform to Outperform 11/12/2024
Maintains Benchmark: Buy to Buy 11/8/2024

Related Tickers